Instil Bio (TIL) Debt Ratio (2020 - 2026)
Instil Bio (TIL) posted quarterly Debt Ratio of 0.42 for Q1 2026, up 19.56% year-over-year from 0.35 in Q1 2025, and up 1.78% quarter-over-quarter from 0.42 in Q4 2025.
Instil Bio (TIL) Debt Ratio (2020 - 2026) Analysis & Trends
Instil Bio's Debt Ratio history runs 7 years deep, the most recent figure standing at 0.42 for Q1 2026.
- In Q1 2026, Debt Ratio rose 19.56% year-over-year to 0.42; the TTM figure through Mar 2026 stood at 0.42 (up 19.56% YoY), while the FY2025 annual figure was 0.42, up 30.45% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.42, up from 0.42 in the prior quarter.
- The five-year high for Debt Ratio was 0.42 in Q1 2026, with the low at 0.0 in Q1 2022.
- The 5-year median for Debt Ratio is 0.27 (2024), against an average of 0.26.
- The sharpest annual moves came in 2022 and 2023: Debt Ratio dropped 24.07% in 2022, then jumped 11674.08% in 2023.
- Instil Bio's Debt Ratio stood at 0.15 in 2022, then jumped by 65.81% to 0.25 in 2023, then gained by 27.74% to 0.32 in 2024, then jumped by 30.45% to 0.42 in 2025, then grew by 1.78% to 0.42 in 2026.
- Business Quant data shows TIL's Debt Ratio at 0.42 in Q1 2026, 0.42 in Q4 2025, and 0.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.47 |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - | 0.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.43 |
| Mar 31, 2026 | 0.42 |
| Dec 31, 2025 | 0.42 |
| Sep 30, 2025 | 0.40 |
| Jun 30, 2025 | 0.37 |
| Mar 31, 2025 | 0.35 |
| Dec 31, 2024 | 0.32 |
| Sep 30, 2024 | 0.30 |
| Jun 30, 2024 | 0.28 |
| Mar 31, 2024 | 0.27 |
| Dec 31, 2023 | 0.25 |
| Sep 30, 2023 | 0.24 |
| Jun 30, 2023 | 0.20 |
| Mar 31, 2023 | 0.18 |
| Dec 31, 2022 | 0.15 |
| Sep 30, 2022 | 0.12 |
| Jun 30, 2022 | 0.09 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |